Most lately, it's been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to some big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts to be a scavenger https://alfredk693ilo3.slypage.com/profile